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4 Abbreviations used in this paper:  
APC: antigen presenting cell 
CIITA : MHC class II transactivator 
IEC: Intestinal epithelial cells  
HSA : Human serum albumin 
MHC: Major histocompatibility complex 
HLA: human leucocyte antigen 
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Abstract 
Background and aims: Intestinal epithelial cells release antigen presenting vesicles 
(exosomes) bearing MHC class II/peptide complexes stimulating specific immune responses 
in vivo. To further characterize the role of human epithelial exosomes in antigen presentation, 
their capacity to load antigenic peptides, to bind immune target cells and to induce T cell 
activation was analyzed in vitro. Methods: The capacity of exosomes derived from the HLA-
DR4 expressing, intestinal epithelial cell line T84, to load the HLA-DR4-specific peptide 3H-
HSA 64-76 and to activate a HLA-DR4-restricted T cell hybridoma, was tested in the 
presence or absence of human monocyte-derived dendritic cells (DCs). Interaction of FITC-
labeled exosomes with T cells and DCs was analyzed by flow cytometry and confocal 
microscopy. Results: T84-derived exosomes, enriched in CD9, CD81, CD82 and A33 
antigen, were capable of binding specifically HSA 64-76 peptide on HLA-DR4 molecules and 
of interacting preferentially with DCs. HSA-loaded exosomes were unable to activate the T 
cell hybridoma directly, but induced a productive T cell activation through DCs. When HSA 
peptide was bound to exosomal HLA-DR4 molecules instead of in a soluble form, the 
threshold of peptide presentation by DCs was markedly decreased (x10-3). Conclusions: 
Exosomes released by intestinal epithelial cells bear exogenous peptides complexed to MHC 
class II molecules and interact preferentially with DCs, strongly potentiating peptide 
presentation to T cells. Epithelial exosomes constitute a powerful link between luminal 
antigens and local immune cells by mediating the transfer of tiny amounts of luminal 
antigenic information and facilitating immune surveillance at mucosal surfaces. 
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INTRODUCTION 
The intestinal epithelium provides a major interface between exogenous antigens present in 
the intestinal lumen and the extensive and important lymphoid tissue disseminated throughout 
the intestinal mucosa. Besides its role in absorption of nutrients and ionic equilibrium, the 
intestinal epithelium constitutes a barrier restricting the passage of incompletely digested 
dietary proteins and excluding infectious particles. Sampling of small amounts of luminal 
content by epithelial cells lining the intestinal lumen is required for the regulation of local 
immune responses. A small portion of the food antigens reaching the small intestine are 
endocytosed non-specifically by intestinal epithelial cells (IECs) and processed in their endo-
lysosomal system. Their degradation products are released into the serosal compartment in the 
form of amino acids and peptides of molecular mass compatible with binding to MHC class II 
molecules (MHC II)1. This intracellular processing of exogenous proteins by IECs is in line 
with their antigen-presenting capacity. In inflammatory conditions in particular2 but also in 
basal conditions3, IECs express MHC II and co-stimulatory molecules4, allowing antigen 
presentation to CD4+ T lymphocytes, at least in vitro. In vivo, IEC can occasionally develop 
projections through pores in the basement membrane5 but direct contact with CD4+ T 
lymphocytes present in the lamina propria is limited. We previously reported that human 
colorectal carcinoma-derived IEC lines (HT29, T84) secrete exosomes6 similar to professional 
antigen presenting cells (APC)7, 8. Epithelial exosomes are enriched in MHC II, CD26 and 
CD63 molecules and display the A33 antigen, an immunoglobulin (Ig)-like molecule9, 10 
specifically expressed in the basolateral membranes of IECs11. Epithelial exosomes convey 
antigenic information and activate humoral and cellular specific immune responses when 
administered intraperitoneally in mice12. The present study was undertaken to better 
understand the mechanisms through which epithelial exosomes transmit immune information 
from IEC to intestinal immune cells. Our results indicate that epithelial exosomes are 
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powerful sensors of luminal antigenic content, interact preferentially with dendritic cells and 
strongly potentiate antigen presentation.  
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MATERIALS AND METHODS: 
Human intestinal cell lines 
Epithelial exosomes were obtained from parental and stably transfected human T84 intestinal 
cell lines. T84 cell lines were engineered to express constitutively high levels of MHC class II 
molecules (HLA-DR) by transfection of cDNAs encoding either the HLA-DRB1*0401 (T84-
DR4/CIITA) or the HLA-DRB1*1101 (T84-DR5/CIITA) molecules, together cDNA 
encoding the MHC class II transactivator, CIITA. These cell lines were provided by 
R.Hershberg13. Cells cultured as previously described6 were seeded (5x106) into 75 cm² 
culture flasks and exosomes were isolated from cell culture supernatants, collected on day 5 
and 7 after plating. In some experiments, cells were seeded on cell culture inserts (Falcon®, 
Becton Dickinson, USA) to collect apical and basolateral epithelial exosomes separately, as 
previously reported 6. 
Preparation of exosomes from intestinal epithelial cell lines and molecular 
characterization 
Cell culture supernatants from culture flasks were pooled and exosomes were isolated as 
previously described6. Each batch of epithelial exosomes was prepared from ten 75cm² 
culture flasks, giving about 60 µg of exosomes. Exosomal proteins were quantified using the 
Bradford protein assay (Bio-rad laboratories GmbH). Exosomes collected from culture 
supernatants of T84-HLA-DR4-CIITA, T84-HLA-DR5-CIITA or wild type T84 intestinal 
epithelial cells are referred as DR4 exos, DR5 exos and control exos, respectively. In some 
experiments, T84-HLA-DR4-CIITA or T84-HLA-DR5-CIITA epithelial cells were incubated 
in the presence of 10 µM (0.6 g/l) human serum albumin (HSA, Sigma Aldrich, France) for 
48 h before the isolation of exosomes (HSA+/DR4 or HSA+/DR5 exosomes, respectively). 
HSA-/DR4 exosomes were obtained in the absence of HSA in the culture medium.  
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Exosomal protein characterization was performed by Western blot analysis after SDS-
polyacrylamide gel electrophoresis under reducing conditions. Blots of T84 intestinal cell 
lysates and T84-derived epithelial exosomes were incubated for 1 h with mouse monoclonal 
IgG1 antibodies recognizing tetraspanins CD9, CD81, CD82 (kindly provided by E. 
Rubinstein) or with the mouse anti-human A33 monoclonal antibody 14. Primary antibodies 
were detected using peroxidase-conjugated sheep anti-mouse immunoglobulin (1/10,000) and 
ECL™ (Amersham Pharmacia Biotech).  
 
Immuno-electron microscopy  
 
Exosomes were placed on formvar carbon-coated EM grids and fixed for 20 min with 2% 
PFA, 0.2% glutaraldehyde (both from Electron Microscopy Sciences, Fort Washington, USA) 
in 0.1M phosphate buffer. Free aldehyde groups were quenched with 50 mM glycine in PBS 
and single immunogold labelings were performed as described15. Briefly, tetraspanins (CD9, 
CD81, CD82) or A33 antigen were labeled using antibodies described above followed by 
rabbit anti-mouse Ig (Dako, Danemark) and protein A conjugated to 10 nm gold particles 
purchased from Cell microscopy center (AZU, Utrecht, the Netherlands). Samples were 
observed under a Philips CM120 Electron Microscope (FEI Company, Eindoven, The 
Netherlands) equipped with a digital camera Keen View (SIS, Germany). 
 
Immune cells 
The EBV-transformed human B cell line (HLA-DR4), kindly provided by S. Zucman (Hôpital 
Necker-Enfants Malades, France), was cultured in RPMI 1640 Glutamax medium (GIBCO, 
Life Technologies, USA) supplemented with 10% FCS, 1% sodium-pyruvate, 1% non 
essential amino-acids, 1% penicillin/streptomycin and 50 mM β-mercaptoethanol. Dendritic 
cells (DCs) were prepared from monocytes (CD14+ cells) isolated from human PBMC [HLA-
DRB1*0401 (HLA-DR4)] or other HLA-DR haplotypes, HLA-DRB1*1001*13 (DR10) and 
HLA-DRB1*1314 (DR13) by negative magnetic depletion (MACS, Miltenyi Biotec, 
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Germany) according to the manufacturer’s instructions (> 90% purity of CD14+ cells). 
Monocytes were induced to differentiate into immature dendritic cells until day 6 in RPMI 
1640 Glutamax medium supplemented with 10% FCS, 4 mM L-glutamine, 1% 
penicillin/streptomycin, 250 ng/ml GM-CSF and 30ng/ml IL-4 (R&D systems Europe, UK). 
DCs were collected and resuspended at 105 cells/200 µl per well in 96-well culture plates 
(Falcon, Becton Dickinson, USA) in complete culture medium supplemented with 250 ng/ml 
GM-CSF and 10 ng/ml IL-4, with or without 100 ng/ml LPS (from Escherichia coli 0127-B8, 
Sigma Aldrich, France) for 40 h, in order to obtain mature or immature dendritic cells (MDCs 
or IDCs), respectively.  
In some experiments, the effect of exosomes on DCs maturation was measured by incubating 
immature DCs in the presence of 5µg of T84-DR4-exosomes. After 48 hour-incubation, 
maturation markers (HLA-DR, CD83, CD86) were assessed by flow cytometry. As a control, 
we used polystyrene polybead® microspheres of 0.1 µm diameter (Polysciences Europe, 
Eppelheim, Germany) incubated with DCs at various concentrations (109 to 1011 beads/ml). 
As effector cells, we used the HSA 64-76 specific, HLA DR4-restricted T cell hybridoma 
17.9 (kindly provided by R.Hershberg), generated after immunization of a DRA*DRB1*0401 
transgenic mouse with HSA16. This hybridoma was cultured in RPMI 1640 Glutamax 
containing 10% FCS, 1% sodium pyruvate (GIBCO, BRL), 1% amino acids, 1% 
penicillin/streptomycin and 50mM β-mercaptoethanol. The T cell receptor of hybridoma 17.9 
can interact with human APC expressing HLA-DR4/HSA 64-76 molecular complexes. The 
activation of the T cell hybridoma, which is fully dependent of TCR activation and does not 
require co-stimulation, was measured by the secretion of murine IL-2 (Duoset ELISA 
Development kit®; R&D systems, UK). 
 
Binding of 3H-HSA 64-76 on HLA-DR molecules of epithelial exosomes 
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HSA 64-76 is a peptide known to bind in the HLA-DR4 pocket and to stimulate the T 
cell hybridoma 17.916. The direct binding of HSA 64-76 on HLA-DR4 molecules of epithelial 
exosomes was measured using a tritiated peptide. HSA 64-76 (VKLVNEVTEFAKT) was 
radio-labeled on the leucine residue. The peptide VK-dehydro-L-VNEVTEFAKT (1 mg) was 
radiolabeled in the presence of tritium gas and purified, yielding pure VK-3,4[3H2] L-
VNEVTEFAKT peptide with a specific radioactivity of 0.37 TBq/mmole. In these conditions, 
the dehydro-leucine was replaced by a tritiated-leucine and the 3H-HSA 64-76 peptide was 
strictly similar to the native peptide. As a negative control, we used 3H-gliadin 57-68 (specific 
radioactivity: 0.40 TBq/mmole), a peptide specific for the HLA-DQ2 pocket but unable to 
bind HLA-DR4. This peptide was tritiated on a proline residue using the same method17.  
Exosomes (20µg) were incubated for 24 h at 37°C with 25 µM of 3H-HSA 64-76 (total 
volume 100µl) or 3H-gliadin 57-68, in phosphate buffer saline 0.1M, pH 7.4. Pellets 
(100,000g 1 h, 4°C) were washed four times with 1 ml PBS. The final supernatant was found 
to contain a negligible amount of radioactivity and discarded, and 3H-radioactivity bound to 
pellets (exosomes) was measured using liquid scintillation photometry (Kontron betamatic, 
France). In some experiments, a 8-mer peptide from glutamic acid decarboxylase (GAD 556-
572), known to bind HLA-DR4 molecules{Wicker, 1996 443 /id}, was used at increasing 
concentrations as a competitive inhibitor (x1, x10 and x25 fold the amount of HSA peptide). 
Non-specific binding of 3H-HSA peptide was measured using control exosomes derived from 
the parental T84 cell line that does not express HLA-DR molecules under basal conditions. 
 
Interaction of epithelial exosomes with immune cells 
To characterize the binding and internalization of epithelial exosomes by different types of 
immune cells, FITC-labeled exosomes were incubated with B-EBV lymphocytes, Jurkat T 
cells, the T cell hybridoma 17.9 or human immature dendritic cells at 4°C (binding) or 37°C 
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(internalisation). The Fluoreporter FITC protein labelling kit (F-6434, Molecular probes) was 
used to label exosomes, according to the manufacturer’s instructions. Exosomes were labeled 
(10µg/50µl) and the excess FITC reactive solution was removed by rinsing (x4) in 1ml PBS. 
The final washing supernatant was used as the negative control in the flow cytometry 
analysis. 
T84-DR4/CIITA and T84-DR5/CIITA-derived exosomes (5µg) were incubated for 3 h at 4°C 
or for 30 min at 37°C with immune cells at 105 cells/well/100 µl in 96-well culture plates. 
Cells were rinsed twice in 200 µl PBS containing 5 mM EDTA and 5% FCS to remove 
weakly adherent exosomes and resuspended. Dendritic cells and B cells were then incubated 
with mouse monoclonal anti-human CD11c and monoclonal anti-HLA-DR (Tü36), 
respectively. T cell hybridoma 17.9 and Jurkat T cells were incubated with mouse monoclonal 
anti-human TCRβ chain antibody (H57-597) and anti-human CD3 (SK7) respectively, for 30 
min at 4°C. Flow cytometry was performed with a BDLSR®using CELLquest® software 
(Becton Dickinson, USA).   
 
Confocal microscopy 
Binding and internalization of epithelial exosomes by dendritic cells and T cell hybridoma 
17.9 was also analyzed by confocal microscopy. FITC-labeled exosomes were incubated with 
monocyte-derived immature dendritic cells and T cell hybridoma at 4°C (binding) or 37°C 
(internalisation). Cells were collected by centrifugation on glass slides (cytospin) and fixed 
with 3.7% formaldehyde. Dendritic cells were labeled with allophycocyanin (APC)-
conjugated anti-CD45 (1/5, Becton Dickinson, Le pont de Claix, France) antibody (control 
isotype IgG1,k) and T cell hybridoma 17.9 was labeled with biotinylated anti-CD3 
monoclonal antibody (IgG1, 20 µg/ml, Becton Dickinson) and revealed with streptavidin-
APC (control isotype biotinylated mouse IgG1). Preparations were mounted using 
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Vectashield mounting medium containing propidium iodide (red nuclear staining, Vector 
Laboratories, France). Microscopic analysis was performed using a LSM 510 ZEISS laser 
scanning confocal microscope. The percentage of labeled cells was evaluated by analyzing a 
total of 400 DCs or T cells. 
 
Antigen presentation assays 
Direct presentation of HSA peptide to T cell hybridoma 17.9 by HSA-loaded exosomes 
The capacity of epithelial exosomes to present HSA peptide 64-76 directly to the T cell 
hybridoma 17.9 was tested. Increasing amounts (0 to 15µg) of HSA-loaded-exosomes were 
incubated with 105 cells /200µl of the T cell hybridoma 17.9 in 96-well culture plates. After 
24 h, T cell activation was measured by assaying murine IL-2 in the culture supernatants. As a 
positive control for antigen presentation, 5 x 104 T84-DR4-CIITA epithelial cells were 
incubated with HSA protein (10µM), or increasing concentrations of the HSA 64-76 peptide, 
before incubation with the T cell hybridoma.  
 
Indirect presentation of HSA peptide to T cell hybridoma 17.9 by HSA-loaded exosomes  
HSA-loaded exosomes were isolated from culture supernatants of T84-DR4-CIITA or -DR5-
CIITA cell lines incubated with 10 µM HSA (HSA+/DR4 exos or HSA+/DR5 exos, 
respectively). Exosomes isolated from T84-DR4-CIITA cells incubated without HSA are 
referred as HSA-/DR4 exos. Monocyte-derived immature or mature dendritic cells (IDCs or 
MDCs), predominantly of the HLA-DRB1*0401 (HLA-DR4) haplotype but also of other 
HLA-DR haplotypes (HLA-DR10 and DR13), were used as antigen presenting cells. The 
phenotype of the DCs was analysed by flow cytometry using FITC-conjugated monoclonal 
anti-CD1a (clone HI149; IgG1,k), FITC- or PE-conjugated anti-CD14 (clone MøP9; 
IgG2b,k), APC-conjugated anti-CD86 (clone FUN-1; IgG1,k), APC-conjugated anti-CD83 
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(clone HB15e; IgG1,k) and PE-conjugated anti-HLA-DR (clone TÜ36; IgG2b,k) all 
purchased from Becton Dickinson. DCs (105 cells/ml) were incubated for 48 h in the presence 
of increasing concentrations of HSA-loaded exosomes (1, 5, 10, 15 µg/200µl) or HSA peptide 
(0.025, 0.25, 2.5, 10, 15, 25 µM). These cells, referred as immature DCs (IDCs), were rinsed 
twice before incubation with 5 x 104 T cell hybridoma 17.9 cells (final volume 200µl). In 
some experiments, DCs were incubated for 2h in the presence of increasing concentrations of 
HSA peptide or exosomes, then LPS was added for 48h before incubation with T cells. These 
DCs are referred as maturing DCs (I/M DCs). Another group of DCs was incubated with LPS 
for 48h, rinsed twice and incubated with HSA-loaded exosomes or HSA peptide for 48h 
before incubation with T cells. These DCs are referred as mature DCs (MDCs). Culture 
supernatants were collected after 24 h and T cell activation was measured by murine IL-2 
release.  
Statistical analysis 
The results are presented as mean ± standard error (SE). Multiple comparisons (analysis of 
variance) followed by group to group comparisons were performed using the general linear 
model procedure of the SAS package (SAS institute, Cary, NC). Non parametric Wilcoxon 
test was also used. Differences were considered to be statistically significant for values of 
p<0.05. 
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RESULTS 
Molecular characterization of epithelial exosomes  
 We have previously demonstrated using mass spectrometry analysis6 that epithelial 
exosomes display antigen presenting molecules such as MHC class I and class II molecules as 
well as the A33 antigen, a marker of the basolateral membranes of intestinal epithelial cells. 
To further characterize the molecules expressed by epithelial exosomes, the presence of the 
tetraspanin molecules, CD9, CD81 and CD82 in T84-DR4/CIITA cell lysates and apical and 
basolateral exosomes was analysed by Western blot. As shown in Fig.1, all tetraspanins are 
highly enriched in exosomes compared to cell lysates, as also reported for exosomes from 
immune cells19. This enrichment is more pronounced in exosomes released from the 
basolateral side of epithelial cells. The presence of the intestinal epithelium-specific A33 
antigen in epithelial exosomes, which we initially demonstrated using mass spectrometry, was 
confirmed here by Western blot analysis. The A33 antigen protein was found to be highly 
enriched in exosomes, particularly basolateral exosomes, compared to cell lysates. 
Tetraspanins and the A33 antigen were shown, using immunogold electron microscopy 
(IEM), to be exposed on the external surfaces of epithelial exosomes. 
 
Exosomal HLA-DR4 molecules bind HSA peptide 
Exosomes released by T84-DR4-CIITA cells constitutively express HLA-DR4 molecules. We 
have previously reported that epithelial exosomes derived from this epithelial cell line display 
MHC class II molecules in a SDS α/β compact form suggesting the presence of functional 
HLA-DR/peptide complexes6. As shown in Fig.2A, 3H-HSA 64-76 binds to control exosomes 
derived from wild type T84 cells (21057 ± 3339 cpm), indicating non-specific interaction. 
However, the binding of HSA peptide to HLA-DR4 (41035 ± 5689 cpm) and HLA-DR5 
(36956 ± 3669 cpm) exosomes is significantly higher than that observed in control exosomes 
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(p<0.01 and 0.04, respectively). In addition, the 3H-HSA 64-76 binding is higher than that 
observed for 3H-gliadin 57-68, a peptide specific of HLA-DQ2 molecules20. The relative 
binding of 3H-HSA peptide to HLA-DR4 and HLA-DR5 molecules is in agreement with their 
theoretical affinity calculated using the RANKPEP method. The predicted binding of MHC-
restricted ligand (the percentile score of HSA 64-76 relative to that of a consensus peptide 
yielding the optimal score) was 43.7 and 11.4 % for HLA-DR4 and HLA-DR5 molecules, 
respectively. Evidence of specific binding of HSA 64-76 to HLA-DR4 molecules was 
provided by an inhibition of 29% and 38% in the presence of increasing amounts (10x and 
25x, respectively) of another HLA-DR4 specific peptide (GAD 556-572) acting as a 
competitor (Fig. 2B). Finally, the HSA peptide binds more efficiently to basolateral than to 
apical exosomes (Fig. 2C), a result which is consistent with the higher density of MHC class 
II molecules in basolateral compared to apical exosomes 6. 
Preferential uptake of epithelial exosomes by dendritic cells 
The capacity of FITC-labeled epithelial exosomes to bind to various types of immune cells 
such as B cells, T cells and DCs, was tested by flow cytometry. Fig.3A indicates that 
epithelial exosomes did not bind to Jurkat T cells and bound only weakly to the B-EBV cell 
line and T cell hybridoma 17.9 at 4°C, whereas a significant binding was observed on 
immature DCs. Increasing the temperature to 37°C induced a minor interaction of exosomes 
with the T cell hybridoma 17.9 but the internalization into DCs was more marked.  
Furthermore, confocal microscopy indicated that immature DCs were capable of 
internalization of FITC-labeled exosomes at 37°C (Fig.3B,C) and that the interaction at 4°C 
was minimal (Fig.3D). The final rinse of the FITC labeling protocol (exos supernatant) 
provided negative controls (not shown). In contrast, exosomes bound to T cell hybridoma 
17.9 at 4°C (Fig.3 G) but they were not internalized at 37°C and remained outside the cells 
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(Fig.3 E,F). Altogether, 42.9 % of dendritic cells and 43 % of T cells were labeled with FITC-
exosomes at 37°C, but only DCs were capable of internalisation.  
Lack of direct activation of T cell hybridoma by HSA-loaded epithelial exosomes 
As exosomes could slightly bind to the T cell hybridoma 17.9, we tested their capacity to 
activate T cells directly through HLA DR4/HSA molecular complexes expressed on their 
surface. HSA-loaded exosomes were not able to induce activation of T cell hybridoma 
directly, as attested by the absence of IL-2 secretion (Fig. 4). In contrast, positive controls 
consisting of T84-DR4-CIITA epithelial cells pre-incubated with HSA protein (10µM) or 
increasing concentrations of HSA-64-76 peptide (0 to 25µM) were capable of activating the T 
cell hybridoma 17.9, as shown by the significant release of IL-2. Incubating T84-DR4-CIITA 
cells with pepsin-trypsin-hydrolyzed HSA did not allow T cell activation (data not shown), 
suggesting that the HSA 64-76 sequence was destroyed in HSA fragments. 
Exosomes induce partial maturation of dendritic cells 
DCs are initially immature cells capable of internalization and processing of environmental 
antigens. Under activation conditions, they are converted to mature DCs that have lost their 
internalization capacity but have up-regulated surface MHC class II- and co-stimulatory- 
molecules and can present antigens efficiently. The pattern of expression of various surface 
molecules on immature and LPS- or exosome- stimulated DCs is shown in Fig.5. During their 
differentiation to immature DCs, monocytes lost CD14 and acquired CD1a, a specific marker 
of DCs (data not shown). Immature DCs expressed CD1a and HLA-DR but not markers of 
maturation such as CD83 and CD86 (co-stimulatory molecules). LPS stimulation induced the 
markers of maturation CD83 and CD86, as expected. Interestingly, epithelial exosomes by 
themselves induced partial maturation of DCs as shown by the increase in CD83 and CD86 
expression. This maturation was not due to LPS-contamination of exosomes, since polymyxin 
B, a LPS binding agent, did not inhibit the maturation process (data not shown). In addition, 
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incubation of immature DCs with inert polystyrene beads at high concentration (1011 
beads/ml) could not induce maturation (Fig.5, last panel) nor could the final supernatant 
obtained during the exosome preparation and the soluble HSA 64-76 peptide alone (data not 
shown). 
 
Epithelial exosomes strongly decrease the threshold of HSA peptide presentation by 
dendritic cells  
Taking into account that epithelial exosomes were not capable of inducing T cell activation 
per se but that they could bind to, and were internalized by DCs, we investigated the ability of 
DCs to present HSA peptide 64-76 via HSA-loaded exosomes. Comparative results of HSA 
peptide presentation to the T cell hybridoma 17.9, by immature, maturing or mature HLA-
DR4 DCs pulsed with soluble HSA peptide 64-76 are shown in Fig 6A. The results obtained 
with immature and maturing DCs were almost similar, indicating that the maturation process, 
in the presence of LPS, does not modify the lowest concentration of peptide able to stimulate 
T cells.  Results obtained with immature, maturing and mature DCs pulsed with HSA+/DR4 
exosomes, HSA+/DR5 exosomes or HSA-/DR4 exosomes, are shown in Fig.6B,C,D. 
Immature DCs (IDCs) induced T cell activation in a concentration-dependent manner with a 
maximal effect at 25µM HSA peptide. The lowest concentration (threshold level) of HSA 
peptide capable of inducing T cell activation significantly was 2.5µM (IL2 = 1.12±0.31 versus 
9.6±2.6 pg/ml in the presence of 0 and 2.5µM HSA peptide concentration respectively, 
p<0.002). Concentrations of 0.025 µM and 0.25µM induced IL2 release (2.27±0.69 and 
3.63±1.44 pg/ml) not significantly different from control (1.12±0.31pg/ml) (Fig.6A). 
Noticeably, IDCs could activate the T cell hybridoma despite the absence of co-stimulatory 
molecules since the hybridoma does not require a co-signal for activation and release of IL-2. 
Meanwhile, MDCs incubated with increasing amounts of HSA peptide did not induce T cell 
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activation. The weak activation observed at the highest HSA peptide concentration (25µM) 
might be due to the HSA peptide loading on HLA-DR4 molecules exposed on the external 
surface of MDCs. 
The incubation of HLA-DR4 IDCs cells with 1, 5, 10 or 15 µg HSA+/DR4-exosomes led to 
the activation of the T cell hybridoma in a concentration-dependent manner (Fig.6B). The 
HSA peptide concentration equivalent to 1, 5, 10 or 15 µg of HSA+/DR4 exosomes was 
estimated from the 3H-HSA peptide loading experiments. By considering the specific activity 
of 3H-HSA peptide 64-76 (0.11 x 108 cpm/nmoles), we calculated the amount of HSA peptide 
loaded on epithelial exosomes by taking into account the radioactivity (cpm) bound to 
HSA+/DR4-exosomes and subtracting the non-specific binding on control exosomes. This 
calculation indicated that 1, 5, 10 and 15µg of HSA+/DR4 exosomes corresponded to 0.0002, 
0.001, 0.002 and 0.003µM HSA peptide, respectively. The results indicate that HLA-DR4 
DCs incubated with 15µg HSA+/DR4 exosomes (containing 0.003µM HSA peptide) can 
activate the T cell hybridoma, whereas an identical concentration of soluble HSA peptide 
cannot. The threshold levels of HSA peptide capable of stimulating the release of ~15 pg/ml 
IL-2 by the T cell hybridoma, when presented via HSA+/DR4 exosomes or as soluble HSA 
peptide, were approximately 0.002µM and 2.5µM, respectively. These results indicate that 
HSA+/exosomes are one thousand times more efficient at stimulating the immune system than 
the HSA peptide alone. In the presence of HSA+/DR5 exosomes, a slight activation of the T 
cell hybridoma was observed (Fig. 6C), suggesting a transfer of HSA peptide from 
HSA+/DR5 exosomes, capable of binding the HSA peptide, to HLA-DR4 molecules on DCs. 
In addition, T cell activation was not induced when HLA-DR4 DCs were incubated with 
HSA-/DR4 exosomes (Fig. 6D). In all experiments, IDCs and I/MDCs behaved similarly, due 
to the fact that activation of T cell hybridoma 17.9 is independent of co-stimulation via CD86. 
Finally, when DCs of HLA-DR10 or DR13 haplotypes were incubated with HSA+/DR4 or 
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HSA+/DR5 exosomes, T cell activation was not observed (Fig.6E, F), a result that strongly 
suggests that the HSA peptide is presented via DCs, rather than HLA-DR-bearing exosomes. 
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DISCUSSION 
The results of this study reinforce the concept that epithelial cells are capable of releasing 
antigen presenting exosomes bearing MHC class II molecule/peptide complexes at their 
surface. Moreover, epithelial exosomes are able to transmit antigenic information to DCs and 
to highly potentiate immune responses by decreasing the threshold levels of antigen 
presentation required for activation.  
Although M cells overlying Peyer’s patches are considered to be a major pathway of antigen 
sampling in the gut, columnar epithelial cells lining the small intestinal mucosa are also able 
to endocytose and degrade proteins and to release protein fragments into the circulation1. 
Epithelial exosomes appear to be efficient intercellular communication vehicles allowing 
protein fragments to escape degradation during transepithelial transport and to transmit 
immune information to local intestinal immune cells.  
The present study reinforces the notion that epithelial exosomes originate from late 
endosomal compartments, as they are strongly enriched in tetraspanins (CD9, CD81, CD82), 
like most types of exosomes21. Tetraspanins mediate cellular penetration, invasion and fusion 
events, and they are part of central supramolecular activation complex in APC22. They are 
also involved in signal transduction in immune cells23, 24, interact with integrins and may be 
responsible for addressing of exosomes to target cells25-27. In addition, and as previously 
described for murine epithelial exosomes12, human intestinal epithelial exosomes are highly 
enriched for the A33 antigen, an immunoglobulin-like protein largely restricted to the 
basolateral membranes of intestinal epithelial cells and whose function is as yet unknown. 
Our in vitro experimental approach indicates that HSA peptide 64-76 can bind specifically to 
HLA-DR4 molecules expressed at the surface of intestinal epithelial exosomes. Indeed, 
although the 3H-HSA peptide can bind non-specifically to parental T84 cell-derived exosomes 
that do not express HLA-DR molecules under basal conditions, it binds specifically to the 
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HLA-DR4 (and to a lower extent to the HLA-DR5) peptide pocket. In addition, competition 
with GAD 556-572, a peptide with a high affinity for the HLA-DR4 pocket, is capable of 
shifting the binding of radio-labelled HSA peptide. Finally, the low binding efficiency of 
gliadin peptide 57-68, a peptide specific for the HLA-DQ2 pocket, to DR4 exosomes, also 
suggests that HSA peptide binding is specific to HLA-DR4 molecules. 
Although epithelial exosomes were shown to expose MHC II /peptide complexes at their 
surface, they could not, by themselves, induce T cell activation, whereas intestinal epithelial 
cells themselves could induce such activation. The absence of co-stimulatory molecules on 
epithelial exosomes6 was not responsible for this lack of activation, however, since the T cell 
hybridoma 17.9, restricted for HLA-DR4 molecules, is capable of direct activation through 
the TCR, even in the absence of co-stimulation.  
Although exosomes have been visualized at the surface of follicular DCs by electron 
microscopy28, little is known about the capacity of these cells to internalize exosomes. Our 
results indicate that epithelial exosomes target DCs more efficiently than other immune cells, 
are internalized by them and induce their partial maturation. Consistent with these favored 
interactions, exosomes are shown here to induce indirect presentation of exogenous peptides 
bound to their HLA-DR molecules via DCs. Such indirect presentation is in line with that 
observed in DC-derived exosomes29, 30 showing that exosomes can stimulate T cell responses 
after interaction with DCs. Indeed, DC-derived exosomes can be internalized and processed 
by immature DCs, for subsequent presentation of exosomal peptides to CD4+ T cells31. 
Exosomes derived from MHC II-engineered rat mast cells also need DCs to efficiently 
activate T cells in vitro32. In our study, non-HLA-DR4 DCs were unable to present HSA 
peptide after incubation with HSA+/DR4-exosomes. This suggests that DC- but not exosome- 
HLA-DR molecules are responsible for HSA peptide presentation to T cells. The involvement 
of DC HLA-DR molecules in antigen presentation is also suggested by the fact that 
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HSA+/DR5 exosomes can transmit HSA peptide to HLA-DR4 DCs, leading to DR4-restricted 
T cell activation. Taking into account that HSA+/DR5 exosomes, potentially bound to the DC 
surface, cannot trigger the HSA-specific, DR4 restricted, T cell hybridoma directly, a transfer 
of HSA peptide from exosome to the DC HLA-DR pocket, is suggested. The stronger T cell 
activation was obtained when exosomes were incubated with IDCs (compared with MDCs), 
indicating that exosome internalization is required to transmit immune information. Indeed, 
IDCs have a high endocytic capacity while MDCs have lost this capacity. In MDCs, the 
membrane expression of MHC class II/peptide complexes and co-stimulatory molecules is up-
regulated compared to IDCs, enabling efficient antigen presentation. In our experimental 
setting, however, IDCs and I/MDCs behaved similarly and IDCs could present the HSA 
peptide due to their high expression of MHC class II molecules and the fact that we used a T 
cell hybridoma that did not require a co-stimulatory signal.  
Epithelial exosomes induced partial maturation of DCs, as shown by the expression of the 
maturation markers CD86 and CD83. This maturation process was a specific phenomenon 
since inert beads of similar size did not induce such maturation. A similar maturation process 
was also reported in response to mast cell-derived exosomes32 and exosomal heat-shock 
proteins (hsp) and their receptors (CD91) were suggested to be responsible for the DC 
maturation. However, a recent study indicated that at least in B cell-derived exosomes, hsps 
are located inside exosomes and cannot trigger DC maturation33.  
An important finding reported here is that epithelial exosomes considerably decrease the 
threshold level of antigenic stimulation required to activate the immune system. Indeed, the 
HSA peptide concentration leading to T cell activation was strongly decreased (x1000) when 
antigenic information was delivered by HSA+/DR4 exosomes rather than by soluble HSA 
peptide alone. T cell activation was not observed when HSA+/exosomes were incubated with 
mature DCs, indicating that exosome internalization and processing is necessary for HSA 
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presentation by DCs and that the binding of exosomes to the surface of mature DCs is not 
sufficient to induce HSA presentation. Rather, internalization of exosomes within DC 
endosomal compartments, known to be enriched in MHC II molecules and presenting an 
optimal microenvironment for peptide loading, may favor peptide exchange between 
exosomal and DC MHC II molecules.   
Altogether, these results suggest that binding of dietary protein fragments to MHC class II 
molecules in intestinal epithelial cells allows the transfer of significant antigenic information 
to the local immune system, through the release of exosomes carrying MHC II/peptide 
complexes. We hypothesize that in vivo, epithelial exosomes transmit antigenic information 
from the intestinal lumen to DCs distributed within the lamina propria. The proposed 
mechanism for the interaction between epithelial exosomes and DCs is schematically depicted 
in Fig.7. DCs may internalize epithelial exosomes released from the basal surface of IECs that 
diffuse towards the lamina propria. This could facilitate the exchange of peptide from HLA-
DR molecules on exosomes to HLA-DR-bearing DCs. Due to the very low threshold levels of 
exosome-linked antigenic material required to stimulate immune cells, epithelial exosomes 
may constitute a powerful vehicle involved in intestinal antigen presentation.  
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Figure legends 
 
Figure 1: Detection of tetraspanins and the A33 antigen in T84-DR4/CIITA cell-derived 
exosomes. 
Western blots indicate that CD9, CD81, CD82 and A33 antigen are expressed by apical (ApE) 
and basolateral (BasE) exosomes and that all markers are highly enriched in exosomes, 
especially in basolateral exosomes, compared to cell lysates (CL). Immunogold electron 
microscopy (IEM) of apical and basolateral exosomes indicates an external, thereby 
potentially functional, localization of these markers (bars = 50 nm). 
Figure 2: Exosomes can load HSA peptide on their HLA-DR4 molecules. 
(A) Binding of 3H-HSA 64-76 and 3H-gliadin 57-68 on HLA-DR4-expressing, HLA-DR5-
expressing and control exosomes. A significant increase in the binding of 3H-HSA peptide is 
observed with HLA-DR4-exosomes, and to a lesser extent with HLA-DR5-exosomes, 
compared to control exosomes (*p<0.01 and # p< 0.04, respectively). Each result is the mean 
of 3 to 9 experiments (mean±SE). 
B) Competitive inhibition of 3H-HSA peptide 64-76 binding to HLA-DR4 molecules by 
increasing concentrations of another HLA-DR4-specific peptide (GAD 556-572). Results are 
the mean of 2 independent experiments.  
 (C) Differential binding of 3H-HSA peptide to apical and basolateral exosomes. Increased 
binding of HSA peptide to basolateral, compared to apical, exosomes was observed, 
consistent with the higher density of MHC class II molecules on basolateral exosomes 6. 
 
Figure 3: Exosomes interact preferentially with DCs  
(A) Flow cytometry analysis of the interaction between FITC-exosomes and B-EBV cells, T 
cells (Jurkat and T cell hybridoma 17.9) or immature dendritic cells (DCs). FITC-exosomes 
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were incubated for 3 h at 4°C or 30 min at 37°C with immune cells and binding (4°C) and 
internalization (37°C) were quantified (black line). Control values (shaded area) were 
provided by the final supernatant from the FITC-exosomes preparation. Binding experiments 
(4°C) indicate that DCs bind FITC-exosomes more efficiently than other immune cells. 
Greater uptake of exosomes (37°C) by DCs compared to poorly internalizing B or T cells was 
observed. One set of data representative of three separate experiments.  
(B to D) Confocal microscopy indicates internalisation of exosomes by dendritic cells.  
Analysis of interactions between FITC-exosomes (green) and DCs (CD45-APC, blue, red 
nuclei) indicates that DCs can efficiently internalize FITC-exosomes at 37°C (B, C) but not at 
4°C (D). The final supernatant from the FITC-exosome preparation provided negative 
controls (not shown).  
(E to G) T cell hybridoma 17.9 was capable of binding FITC-exosomes at 37°C, but no 
internalisation could be observed.  
Results are representative of two independent experiments.  
 
Figure 4: Absence of direct activation of T cells by epithelial exosomes.  
Activation of the T cell hybridoma 17.9 was measured by IL-2 release after 24 h incubation 
with increasing amounts of HSA+/DR4 exosomes. As a positive control for antigen 
presentation, the T84-DR4-CIITA epithelial cell line was incubated for 24 h with increasing 
concentrations of HSA peptide or with intact HSA, before incubation with T cell hybridoma. 
The results indicate that exosomes, in contrast to epithelial cells, cannot activate the T cell 
hybridoma directly. Data are means ± SE of three separate experiments.  
 
Figure 5: Effect of epithelial exosomes on DC maturation. 
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Flow cytometry analysis of immature DCs cultured in the absence or presence of LPS or 
epithelial exosomes. LPS induces the expression of maturation markers such as CD86 and 
CD83 as expected. Epithelial exosomes also partially induce maturation of DCs as shown by 
the increased expression of maturation markers. Exosome-induced maturation of DCs was not 
due to LPS-contamination of exosomes, since the addition to exosomes of polymyxin B, a 
LPS binding agent, did not inhibit the maturation process. In addition, polystyrene polybead® 
microsphere of 0.1 µm diameter (similar to exosome diameter) at concentrations up to 1011 
beads/ml (result shown: 1011 beads/ml) did not induced DCs maturation, indicating that the 
maturation process induced by exosomes is a specific phenomenon.  
Blank histograms: antibody labeling, solid histograms: isotype controls. 
 
Figure 6: Epithelial exosomes transmit HSA peptide and potentiate its presentation by 
dendritic cells. 
(A): DR4-DCs present HSA peptide to the T cell hybridoma. Immature, maturing or mature 
DCs (IDCs, I/MDCs, MDCs) were incubated for 48 h with increasing concentrations of HSA 
peptide. Immature, maturing and to a much lesser extent mature DCs induce a concentration-
dependent T cell activation with a maximal effect observed with 25 µM HSA peptide. The 
threshold concentration of peptide required to stimulate significantly T cell activation is 2.5 
µM. 
Data are the means ±SE of 6 independent experiments. 
 
(B):  DR4-DCs present HSA peptide loaded on epithelial exosomes to T cell hybridoma.  
Immature DR4-DCs incubated in the presence of increasing concentrations of HSA+/DR4 
exosomes (1 to 15 µg) induce a dose-dependent T cell activation (the corresponding HSA 
peptide concentrations bound to exosomes are indicated in parentheses). Under these 
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conditions, the threshold of peptide concentration stimulating T cell activation is 
approximately 0.002 µM. Thus, HSA-loaded exosomes are much more efficient than soluble 
HSA peptide in activating the T cell hybridoma.via DCs.  
 (C): DR4-DCs incubated with HSA+/DR5 exosomes are able to induce activation of the T 
cell hybridoma. Increasing concentrations of HSA+/DR5 exosomes induce less IL-2 secretion 
than that observed with HSA+/DR4 exosomes, consistent with the lower affinity of HSA 
peptide for HLA-DR5 compared to HLA-DR4 molecules. This result also indicates that the 
HSA peptide is transferred from HLA-DR5 molecules on exosomes to HLA-DR4 molecules 
on DCs. Data are the means ± SE of 6 independent experiments. 
(D): DR4-DCs incubated with HSA-/DR4 exosomes (prepared in the absence of HSA), are 
unable to induce activation of T cells.  
(E): DR10- or DR13-DCs incubated with HSA+/DR4 exosomes do not activate T cells 
indicating that HLA-DR4 molecules of dendritic cells are necessary to HSA peptide 
presentation (results are means of two experiments).  
(F): DR10-DCs incubated with HSA+/DR5 exosomes do not activate T cells.   
 
Figure 7: Hypothetical model of peptide transfer from epithelial exosomes to DCs. 
           Intestinal epithelial cells (IECs) release exosomes bearing MHC class II/peptide complexes 
that interact with immature DCs. After binding at the DC surface, they are endocytosed and 
conveyed to multivesicular body (MVB) compartments where peptide exchange from 
exosome to DC-harboring MHC class II molecules can take place. Peptide-loaded MHC II 
complexes are then exposed at the DC plasma membrane to trigger activation of CD4+ T 
cells. 
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